SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of February 5, 2026, SNN stock price climbed to $35.17 with 1,449,890 million shares trading.

SNN has a beta of 0.70, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.18 to the broad based SPY ETF.

SNN has a market cap of $14.92 billion. This is considered a Large Cap stock.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): AVDE, BINV, DFIC, KOMP, APIE.

SNN has outperformed the market in the last year with a price return of +39.6% while the SPY ETF gained +13.8%. However, in the short term, SNN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -5.0% vs +0.6% return in SPY. But in the last 2 weeks, SNN shares have fared better than the market returning +7.3% compared to SPY -1.1%.

SNN support price is $34.51 and resistance is $35.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.